secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEPHROS INC (NEPH)
CIK:        0001196298
Form:       8-K
Filed at:   2022-07-06T23:59:59+00:00
Accession:  0001493152-22-018632
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nephros prelim Q2 revenue $2.9M, up 27% YoY; expects positive net cash flow in 12 months
--------------------------------------------------------------------------------

- Q2 2022 preliminary net revenue ~$2.9M, a 27% increase from $2.3M in Q2 2021.
- Active customer sites grew 21% YoY to 1,349, adding 232 sites in trailing 12 months.
- Expense management plan includes headcount reductions and facility consolidations; company projects positive net cash flow within 12 months.
- Ended Q2 with approximately $4.2M in cash on a consolidated basis.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1196298/000149315222018632/0001493152-22-018632-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1196298/000149315222018632/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-018632

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer